Volume | 154,831 |
|
|||||
News | - | ||||||
Day High | 44.48 | Low High |
|||||
Day Low | 40.6948 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Arcturus Therapeutics Holdings Inc | ARCT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
41.44 | 40.6948 | 44.48 | 41.42 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
3,250 | 154,831 | US$ 42.68 | US$ 6,607,589 | - | 17.52 - 44.48 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
10:33:58 | 3 | US$ 44.405 | USD |
Arcturus Therapeutics Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.17B | 26.92M | - | 166.8M | -29.73M | -1.10 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Arcturus Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARCT Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 37.37 | 44.48 | 36.02 | 39.17 | 572,551 | 7.03 | 18.81% |
1 Month | 27.11 | 44.48 | 26.28 | 33.45 | 493,806 | 17.29 | 63.78% |
3 Months | 38.75 | 44.48 | 25.41 | 31.62 | 516,995 | 5.65 | 14.58% |
6 Months | 23.83 | 44.48 | 22.35 | 32.68 | 465,398 | 20.57 | 86.32% |
1 Year | 26.66 | 44.48 | 17.52 | 30.08 | 441,137 | 17.74 | 66.54% |
3 Years | 30.95 | 64.9735 | 11.70 | 29.13 | 536,786 | 13.45 | 43.46% |
5 Years | 7.15 | 129.71 | 5.75 | 39.39 | 571,467 | 37.25 | 520.98% |
Arcturus Therapeutics Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19. |